Clinical Trial

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

Name: Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis — clinical trial record (NCT06792344)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-01-20.

Trial Details

NCT Number	NCT06792344
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine Collaborators: Guangzhou Women and Children's Medical Center
Conditions	Systemic Sclerosis (SSc)
Enrollment	12 participants
Start Date	2024-12-15
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-22